SCHEMBL30994530

SCHEMBL30994530

Oc1cc(N(c2ccccc2-c2ccccc2)c2cccc3c2oc2ccccc23)ccc1-c1ccc(N(c2ccccc2-c2ccccc2)c2cccc3c2oc2ccccc23)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.47
GGPS1 O95749 1/20 0.34
CDC14B O60729 2/20 0.33
CDC14A Q9UNH5 2/20 0.33
PTGES2 Q9H7Z7 1/20 0.32
MAOA P21397 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
CYP3A4 P08684 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
RECQL P46063 2/20 0.32
KMT2A Q03164 2/20 0.32
HSD17B10 Q99714 2/20 0.32
MCL1 Q07820 2/20 0.32
ALPI P09923 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
CASP3 P42574 1/20 0.32
BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24472093 0.87 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL17879922 0.86 ALOX5 (0.42) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL30214106 0.85 ALOX5 (0.38) ALOX5KDM4ECYP3A4HSD17B10BLM
SCHEMBL29275761 0.85 ALOX5 (0.38) ALOX5KDM4ECYP3A4HSD17B10BLM
SCHEMBL26687157 0.84 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL26687144 0.84 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL24472625 0.84 ALOX5 (0.45) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL24472105 0.84 ALOX5 (0.45) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL16883029 0.84 ALOX5 (0.42) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL24472078 0.84 ALOX5 (0.45) ALOX5GGPS1CDC14BCDC14APTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262806-A1 INHIBITORS OF NLRP3 PCT THERAPEUTICS, INC. (US) 2024-08-08 US claimed
CN-118302417-A NLRP3 inhibitors PTC医疗公司 2024-07-05 CN claimed
US-20240262806-A1 INHIBITORS OF NLRP3 PCT THERAPEUTICS, INC. (US) 2024-08-08 US disclosed
CN-118302417-A NLRP3 inhibitors PTC医疗公司 2024-07-05 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240262806-A1 INHIBITORS OF NLRP3 NLRP3, NOD1, NLRP1 ALOX5 1714/4885GGPS1 1673/4885CDC14B 4564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.